SCIENTIFIC POSTER

EpiScreen® 2.0 Time Course Assay: A Sensitive & Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologic

This study introduces a next-generation immunogenicity assay designed to enhance sensitivity without sacrificing specificity or accuracy in determining mechanisms of action. The optimized assay empowers researchers with more reliable preclinical immunogenicity risk assessments and data-driven lead selection, offering a higher degree of confidence in early-stage drug development.

EpiScreen-2.0-Time-Course-Assay-AAPS-Poster-Abzena-1

What’s Inside?

Discover how this assay presents a new and much improved preclinical immunogenicity testing method for biologics, which is sensitive, specific, data-rich, MoA-reflective and customizable.

Download the Case Study

Let's move medicine forward

The asset you’re developing right now can make a real difference for human health. Let us use our wealth of experience to deploy the best technologies, shorten lead times and implement effective risk mitigation strategies.